An explanation for the ability of cytotoxic drug pretreatment to reduce bone marrow related lethality of total body irradiation (TBI).
D000818:Animals; D000970:Antineoplastic Agents / Q000494:pharmacology*; D001853:Bone Marrow / Q000528:radiation effects*; D003114:Colony-Forming Units Assay; D003561:Cytarabine / Q000494:pharmacology; D005260:Female; D006412:Hematopoietic Stem Cells / Q000528:radiation effects; D008175:Lung Neoplasms / Q000532:radiotherapy; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008808:Mice, Inbred CBA; D011837:Radiation-Protective Agents; D013997:Time Factors; D014916:Whole-Body Irradiation
D000970:Antineoplastic Agents; D011837:Radiation-Protective Agents; D003561:Cytarabine